Portfolio company
Atlas Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops deep learning software for pharmaceutical firms to predict molecular interactions and simulate animal testing during drug development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Deep Origin
This company provides a computational drug discovery platform for biopharmaceutical researchers to simulate molecular properties and accelerate therapeutic development.
Axiom Bio
This company develops artificial intelligence models that predict drug toxicity to help pharmaceutical researchers identify safety risks early in the development process.
Chai Discovery
This company develops artificial intelligence models to predict and design molecular structures and protein binders for pharmaceutical and life sciences researchers.
Achira
This company develops atomistic simulation software combining physics and machine learning to enable drug discovery for biotechnology and pharmaceutical organisations.
Deep MedChem
This company develops artificial intelligence software for virtual screening and molecular discovery for pharmaceutical, biotechnology and academic drug discovery teams.
Arrepath
This company develops oral small-molecule drugs for the pharmaceutical industry using artificial intelligence and machine learning workflows.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Khumbu
This company develops artificial intelligence models for molecular biology and protein-ligand interactions to accelerate drug discovery for the pharmaceutical industry.
